Alexa P Kollmeier

6PUBLICATIONS
30CO-AUTHORS
Rheumatology and arthritisClinical neuropsychologyAllergyPharmacogenomicsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 13, 2024
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis.

Proton Rahman, Iain B McInnes, Atul Deodhar

|Feb 22, 2024
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.

Jeffrey R Curtis, Iain B McInnes, Proton Rahman

|Jan 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis.

Stefan Siebert, Laura C Coates, Georg Schett

|Oct 31, 2023
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis.

Bruce Strober, Laura C Coates, Mark G Lebwohl

|Oct 03, 2023
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.

Philip J Mease, Alice B Gottlieb, Alexis Ogdie

|Apr 24, 2018
Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H<sub>4</sub> R-antagonist (JNJ-39758979) in adults with uncontrolled asthma.

A P Kollmeier, A Greenspan, X L Xu

Pageof 1

Frequent Collaborators

5 joint publications

May Shawi

5 joint publications

Proton Rahman

4 joint publications

Phillip J Mease

3 joint publications

Iain B McInnes